83 FR 27070 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 83, Issue 112 (June 11, 2018)
Federal Motor Carrier Safety Administration
Federal Register Volume 83, Issue 112 (June 11, 2018)
| Page Range | 27070-27076 | |
| FR Document | 2018-12473 |
[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)] [Notices] [Pages 27070-27076] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-12473] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2018-0030] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of applications for exemption; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 41 individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with insulin-treated diabetes mellitus (ITDM) operating a commercial motor vehicle (CMV) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before July 11, 2018. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2018-0030 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., e.t., [[Page 27071]] Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket number(s) for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The FDMS is available 24 hours each day e.t., 365 days each year. If you want acknowledgment that we received your comments, please include a self-addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments online. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to http://www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at http://www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the FMCSRs for a five-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the five-year period. FMCSA grants exemptions from the FMCSRs for a two- year period to align with the maximum duration of a driver's medical certification. The 41 individuals listed in this notice have requested an exemption from the diabetes prohibition in 49 CFR 391.41(b)(3). Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. The physical qualification standard for drivers regarding diabetes found in 49 CFR 391.41(b)(3) states that a person is physically qualified to drive a CMV if that person has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control. The Agency established the current requirement for diabetes in 1970 because several risk studies indicated that drivers with diabetes had a higher rate of crash involvement than the general population. FMCSA established its diabetes exemption program, based on the Agency's July 2000 study entitled ``A Report to Congress on the Feasibility of a Program to Qualify Individuals with Insulin-Treated Diabetes Mellitus to Operate in Interstate Commerce as Directed by the Transportation Act for the 21st Century.'' The report concluded that a safe and practicable protocol to allow some drivers with ITDM to operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal Register notice in conjunction with the November 8, 2005 (70 FR 67777), Federal Register notice provides the current protocol for allowing such drivers to operate CMVs in interstate commerce. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441). The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). Section 4129 requires: (1) Elimination of the requirement for three years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the three-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C. 31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003, notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003, notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. II. Qualifications of Applicants Gerardo Arredondo Mr. Arredondo, 56, has had ITDM since 2011. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Arredondo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Arredondo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Texas. Ammar H. Atieh Mr. Atieh, 22, has had ITDM since 2004. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Atieh understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Atieh meets the requirements of the vision standard at 49 CFR [[Page 27072]] 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Robert P. Baker, Jr. Mr. Baker, 37, has had ITDM since 2002. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Baker understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Baker meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's from Indiana. Jose A. Barron Mr. Barron, 62, has had ITDM since 2008. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Barron understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Barron meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Texas. Michael D. Cash Mr. Cash, 51, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Cash understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cash meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from New York. Travis A. Chandler Mr. Chandler, 31, has had ITDM since 1998. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Chandler understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Chandler meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Tennessee. Curtis D. Dement Mr. Dement, 63, has had ITDM since 2018. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Dement understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Dement meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from North Dakota. Mark A. Duncan Mr. Duncan, 56, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Duncan understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Duncan meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Kansas. Hugh J. Gallagher Mr. Gallagher, 57, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Gallagher understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gallagher meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Indiana. Charles Gant Mr. Gant, 48, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Gant understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gant meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Gary D. Gudeman Mr. Gudeman, 60, has had ITDM since 2013. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist [[Page 27073]] certifies that Mr. Gudeman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gudeman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Indiana. Richard D. Hawkins Mr. Hawkins, 43, has had ITDM since 2007. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Hawkins understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hawkins meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Indiana. Michael A. Hayes Mr. Hayes, 43, has had ITDM since 2018. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Hayes understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hayes meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from North Carolina.4 Brent M. Howard Mr. Howard, 55, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Howard understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Howard meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Iowa. Herbert O. Jenkins Mr. Jenkins, 55, has had ITDM since 1992. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Jenkins understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Jenkins meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable proliferative diabetic retinopathy. He holds an operator's license from Kentucky. Scott A. Kiel Mr. Kiel, 52, has had ITDM since 2018. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Kiel understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kiel meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from North Dakota. Barry T. Koch Mr. Koch, 59, has had ITDM since 2010. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Koch understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Koch meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Pennsylvania. Jose Lares Mr. Lares, 59, has had ITDM since 2018. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Lares understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lares meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Arizona. John A. Larson Mr. Larson, 67, has had ITDM since 2011. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Larson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Larson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Brian T. Lewis Mr. Lewis, 52, has had ITDM since 2017. His endocrinologist examined him [[Page 27074]] in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Lewis understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lewis meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from California. Mark J. Longtin Mr. Longtin, 66, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Longtin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Longtin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from South Dakota. Christopher A. Marquette Mr. Marquette, 37, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Marquette understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Marquette meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Kasey J. Martin Mr. Martin, 28, has had ITDM since 2010. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Martin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Martin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Indiana. David A. Martin Mr. Martin, 60, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Martin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Martin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. Ryan J. Matthews Mr. Matthews, 39, has had ITDM since 1995. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Matthews understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Matthews meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Ohio. Gion H. Mersha Mr. Mersha, 44, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Mersha understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mersha meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Iowa. Phillip A. Nass Mr. Nass, 65, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Nass understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Nass meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Frank T. Piper, Jr. Mr. Piper, 65, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Piper understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV [[Page 27075]] safely. Mr. Piper meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Connecticut. James P. Renaud Mr. Renaud, 49, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Renaud understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Renaud meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from New Hampshire. Charles D. Robison Mr. Robison, 56, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Robison understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Robison meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Michael A. Roosa Mr. Roosa, 53, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Roosa understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Roosa meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Massachusetts. Alan Sang Mr. Sang, 48, has had ITDM since 2015. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Sang understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Sang meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Florida. James M. Sanicola Mr. Sanicola, 61, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Sanicola understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Sanicola meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Wisconsin. Michael J. Torrez Mr. Torrez, 58, has had ITDM since 2018. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Torrez understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Torrez meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Gerard N. Tremblay, Jr. Mr. Tremblay, 48, has had ITDM since 2010. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Tremblay understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tremblay meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds an operator's license from Massachusetts. John H. Turner Mr. Turner, 73, has had ITDM since 2017. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Turner understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Turner meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Marcus D. Wade Mr. Wade, 24, has had ITDM since 2013. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or [[Page 27076]] more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Wade understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wade meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Illinois. James A. White Mr. White, 55, has had ITDM since 2013. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. White understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. White meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Louisiana. Theodore M. Wicks Mr. Wicks, 66, has had ITDM since 2016. His endocrinologist examined him in 2018 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Wicks understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wicks meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wyoming. Raymond L. Williamson Mr. Williamson, 66, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Williamson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Williamson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. Steve B. Winger Mr. Winger, 60, has had ITDM since 2012. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Winger understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Winger meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2018 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Montana. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the dates section of the notice. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2018-0030 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and materials received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2018-0030 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: June 5, 2018. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2018-12473 Filed 6-8-18; 8:45 am] BILLING CODE 4910-EX-P
![27070 Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
www.regulations.gov. Follow the attaching a document using an ‘‘upload comments USTR receives regarding the
instructions for submitting comments in file’’ field. USTR prefers that comments dispute. If a dispute settlement panel is
section III below. The docket number is be provided in an attached document. If convened, or in the event of an appeal
USTR–2018–0014. For alternatives to a document is attached, it is sufficient of a panel report, USTR will make the
on-line submissions, please contact to type ‘‘see attached’’ in the ‘‘type following documents publicly available
Sandy McKinzy at (202) 395–9483. comment’’ field. USTR prefers at www.ustr.gov: The U.S. submissions
FOR FURTHER INFORMATION CONTACT: submissions in Microsoft Word (.doc) or and any non-confidential summaries of
Assistant General Counsel Juli Schwartz Adobe Acrobat (.pdf). If the submission submissions received from other
at (202) 395–3150. is in an application other than those participants in the dispute. If a dispute
SUPPLEMENTARY INFORMATION: two, please indicate the name of the settlement panel is convened, the report
application in the ‘‘type comment’’ of the panel, and, in the event of an
I. Background field. appeal of a panel report, the report of
USTR is providing notice that Korea For any comments submitted the Appellate Body, will also be
has requested consultations pursuant to electronically containing business available on the website of the World
the WTO Understanding on Rules and confidential information, the file name Trade Organization, at www.wto.org.
Procedures Governing the Settlement of of the business confidential version
should begin with the characters ‘‘BC’’. Juan Millan,
Disputes (DSU), the General Agreement
on Tariffs and Trade 1994, and the Any page containing business Assistant United States Trade Representative
confidential information must be clearly for Monitoring and Enforcement Office of the
Agreement on Safeguards (SGA). If
marked ‘‘BUSINESS CONFIDENTIAL’’ U.S. Trade Representative.
these consultations do not resolve the
on the top of that page and the [FR Doc. 2018–12447 Filed 6–8–18; 8:45 am]
matter, Korea could request that the
WTO establish a dispute settlement submission should clearly indicate, via BILLING CODE 3290–F8–P
panel pursuant to the DSU, which brackets, highlighting, or other means,
would hold its meetings in Geneva, the specific information that is business
Switzerland, and issue a report on its confidential. If you request business DEPARTMENT OF TRANSPORTATION
findings. confidential treatment, you must certify
in writing that disclosure of the Federal Motor Carrier Safety
II. Major Issues Raised by Korea information would endanger trade Administration
On May 14, 2018, Korea requested secrets or profitability, and that the [Docket No. FMCSA–2018–0030]
consultations concerning the safeguard information would not customarily be
measure in effect pursuant to released to the public. Filers of Qualification of Drivers; Exemption
Proclamation 9594 of January 23, submissions containing business Applications; Diabetes Mellitus
2018—To Facilitate a Positive confidential information also must
Adjustment to Competition from submit a public version of their AGENCY: Federal Motor Carrier Safety
Imports of Large Residential Washers, comments. The file name of the public Administration (FMCSA), DOT.
83 FR 3553 (Jan. 25, 2018). Korea alleges version should begin with the character ACTION: Notice of applications for
that the United States’ safeguard action ‘‘P’’. The ‘‘BC’’ and ‘‘P’’ should be exemption; request for comments.
is inconsistent with Articles I:1, II, X:3, followed by the name of the person or
SUMMARY: FMCSA announces receipt of
and XIX:1 of the GATT 1994 and entity submitting the comments or
Articles 2.1, 2.2, 3.1, 3.2, 4.1, 4.2, 5.1, applications from 41 individuals for an
rebuttal comments. If these procedures
7.1, 7.4, 8.1, 12.1, 12.2, and 12.3 of the are not sufficient to protect business exemption from the prohibition in the
SGA. confidential information or otherwise Federal Motor Carrier Safety
protect business interests, please contact Regulations (FMCSRs) against persons
III. Public Comments: Requirements for with insulin-treated diabetes mellitus
Sandy McKinzy at (202) 395–9483 to
Submissions (ITDM) operating a commercial motor
discuss whether alternative
USTR invites written comments arrangements are possible. vehicle (CMV) in interstate commerce. If
concerning the issues raised in this USTR may determine that information granted, the exemptions would enable
dispute. All submissions must be in or advice contained in a comment, other these individuals with ITDM to operate
English and sent electronically via than business confidential information, CMVs in interstate commerce.
www.regulations.gov. To submit is confidential in accordance with DATES: Comments must be received on
comments via www.regulations.gov, section 135(g)(2) of the Trade Act of or before July 11, 2018.
enter docket number USTR–2018–0014 1974 (19 U.S.C. 2155(g)(2)). If a ADDRESSES: You may submit comments
on the home page and click ‘‘search.’’ submitter believes that information or bearing the Federal Docket Management
The site will provide a search-results advice is confidential, s/he must clearly System (FDMS) Docket No. FMCSA–
page listing all documents associated designate the information or advice as 2018–0030 using any of the following
with this docket. Find a reference to this confidential and mark it as methods:
notice by selecting ‘‘notice’’ under ‘‘SUBMITTED IN CONFIDENCE’’ at the • Federal eRulemaking Portal: Go to
‘‘document type’’ on the left side of the top and bottom of the cover page and http://www.regulations.gov. Follow the
search-results page, and click on the each succeeding page, and provide a online instructions for submitting
link entitled ‘‘comment now!’’ For non-confidential summary of the comments.
further information on using the information or advice. • Mail: Docket Management Facility;
www.regulations.gov website, please Pursuant to section 127(e) of the U.S. Department of Transportation, 1200
daltland on DSKBBV9HB2PROD with NOTICES
consult the resources provided on the Uruguay Round Agreements Act (19 New Jersey Avenue SE, West Building
website by clicking on ‘‘How to Use U.S.C. 3537(e)), USTR will maintain a Ground Floor, Room W12–140,
Regulations.gov’’ on the bottom of the docket on this dispute settlement Washington, DC 20590–0001.
home page. proceeding, docket number USTR– • Hand Delivery: West Building
The www.regulations.gov website 2018–0014, accessible to the public at Ground Floor, Room W12–140, 1200
allows users to provide comments by www.regulations.gov. The public file New Jersey Avenue SE, Washington,
filling in a ‘‘type comment’’ field, or by will include non-confidential public DC, between 9 a.m. and 5 p.m., e.t.,
VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 PO 00000 Frm 00126 Fmt 4703 Sfmt 4703 E:\FR\FM\11JNN1.SGM 11JNN1](https://thefederalregister.org/doc/83_FR_27182/page/1.svg)
![27076 Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
more) severe hypoglycemic episodes in occurred without warning in the past 12 specific section of this document to
the last five years. His endocrinologist months and no recurrent (two or more) which each comment applies, and
certifies that Mr. Wade understands severe hypoglycemic episodes in the provide a reason for each suggestion or
diabetes management and monitoring, last five years. His endocrinologist recommendation. If you submit your
has stable control of his diabetes using certifies that Mr. Williamson comments by mail or hand delivery,
insulin, and is able to drive a CMV understands diabetes management and submit them in an unbound format, no
safely. Mr. Wade meets the monitoring, has stable control of his larger than 81⁄2 by 11 inches, suitable for
requirements of the vision standard at diabetes using insulin, and is able to copying and electronic filing. If you
49 CFR 391.41(b)(10). His optometrist drive a CMV safely. Mr. Williamson submit comments by mail and would
examined him in 2017 and certified that meets the requirements of the vision like to know that they reached the
he does not have diabetic retinopathy. standard at 49 CFR 391.41(b)(10). His facility, please enclose a stamped, self-
He holds an operator’s license from optometrist examined him in 2017 and addressed postcard or envelope.
Illinois. certified that he does not have diabetic We will consider all comments and
retinopathy. He holds a Class A CDL materials received during the comment
James A. White period. FMCSA may issue a final
from Illinois.
Mr. White, 55, has had ITDM since determination at any time after the close
2013. His endocrinologist examined him Steve B. Winger of the comment period.
in 2018 and certified that he has had no Mr. Winger, 60, has had ITDM since
severe hypoglycemic reactions resulting 2012. His endocrinologist examined him V. Viewing Comments and Documents
in loss of consciousness, requiring the in 2017 and certified that he has had no To view comments, as well as any
assistance of another person, or severe hypoglycemic reactions resulting documents mentioned in this preamble,
resulting in impaired cognitive function in loss of consciousness, requiring the go to http://www.regulations.gov and in
that occurred without warning in the assistance of another person, or the search box insert the docket number
past 12 months and no recurrent (two or resulting in impaired cognitive function FMCSA–2018–0030 and click ‘‘Search.’’
more) severe hypoglycemic episodes in that occurred without warning in the Next, click ‘‘Open Docket Folder’’ and
the last five years. His endocrinologist past 12 months and no recurrent (two or you will find all documents and
certifies that Mr. White understands more) severe hypoglycemic episodes in comments related to this notice.
diabetes management and monitoring, the last five years. His endocrinologist Issued on: June 5, 2018.
has stable control of his diabetes using certifies that Mr. Winger understands Larry W. Minor,
insulin, and is able to drive a CMV diabetes management and monitoring, Associate Administrator for Policy.
safely. Mr. White meets the has stable control of his diabetes using [FR Doc. 2018–12473 Filed 6–8–18; 8:45 am]
requirements of the vision standard at insulin, and is able to drive a CMV
BILLING CODE 4910–EX–P
49 CFR 391.41(b)(10). His optometrist safely. Mr. Winger meets the
examined him in 2018 and certified that requirements of the vision standard at
he does not have diabetic retinopathy. 49 CFR 391.41(b)(10). His optometrist DEPARTMENT OF TRANSPORTATION
He holds a Class A CDL from Louisiana. examined him in 2018 and certified that
Theodore M. Wicks he does not have diabetic retinopathy. Pipeline and Hazardous Materials
He holds a Class A CDL from Montana. Safety Administration
Mr. Wicks, 66, has had ITDM since
2016. His endocrinologist examined him III. Request for Comments Hazardous Materials: Notice of
in 2018 and certified that he has had no In accordance with 49 U.S.C. 31136(e) Applications for Special Permits
severe hypoglycemic reactions resulting and 31315, FMCSA requests public
in loss of consciousness, requiring the comment from all interested persons on AGENCY: Pipeline and Hazardous
assistance of another person, or the exemption petitions described in Materials Safety Administration
resulting in impaired cognitive function this notice. We will consider all (PHMSA), DOT.
that occurred without warning in the comments received before the close of ACTION: List of applications for
past 12 months and no recurrent (two or business on the closing date indicated modification of special permits.
more) severe hypoglycemic episodes in in the dates section of the notice. SUMMARY: In accordance with the
the last five years. His endocrinologist procedures governing the application
certifies that Mr. Wicks understands IV. Submitting Comments
You may submit your comments and for, and the processing of, special
diabetes management and monitoring, permits from the Department of
has stable control of his diabetes using material online or by fax, mail, or hand
delivery, but please use only one of Transportation’s Hazardous Material
insulin, and is able to drive a CMV Regulations, notice is hereby given that
safely. Mr. Wicks meets the these means. FMCSA recommends that
you include your name and a mailing the Office of Hazardous Materials Safety
requirements of the vision standard at has received the application described
49 CFR 391.41(b)(10). His optometrist address, an email address, or a phone
number in the body of your document herein.
examined him in 2017 and certified that
he does not have diabetic retinopathy. so that FMCSA can contact you if there DATES: Comments must be received on
He holds a Class A CDL from Wyoming. are questions regarding your or before June 26, 2018.
submission. ADDRESSES: Record Center, Pipeline and
Raymond L. Williamson To submit your comment online, go to Hazardous Materials Safety
Mr. Williamson, 66, has had ITDM http://www.regulations.gov and in the Administration, U.S. Department of
daltland on DSKBBV9HB2PROD with NOTICES
since 2017. His endocrinologist search box insert the docket number Transportation, Washington, DC 20590.
examined him in 2017 and certified that FMCSA–2018–0030 and click the search Comments should refer to the
he has had no severe hypoglycemic button. When the new screen appears, application number and be submitted in
reactions resulting in loss of click on the blue ‘‘Comment Now!’’ triplicate. If confirmation of receipt of
consciousness, requiring the assistance button on the right hand side of the comments is desired, include a self-
of another person, or resulting in page. On the new page, enter addressed stamped postcard showing
impaired cognitive function that information required including the the special permit number.
VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 PO 00000 Frm 00132 Fmt 4703 Sfmt 4703 E:\FR\FM\11JNN1.SGM 11JNN1](https://thefederalregister.org/doc/83_FR_27182/page/7.svg)
Document Created: 2018-11-02 11:59:26
Document Modified: 2018-11-02 11:59:26
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemption; request for comments. | |
| Dates | Comments must be received on or before July 11, 2018. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826. | |
| FR Citation | 83 FR 27070 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR